Most recently, he was President and Chief Financial Officer of Bausch & Lomb where he played a key role in preparing the company for an initial public offering until its sale to Valeant Pharmaceuticals. In May 2017, he assumed the role of chairman of the board. From July 2005 to October 2014 she served as professor of the practice of molecular and cell biology at Harvard University.In 2005, Dr. Sato retired as President of Vertex Pharmaceuticals Incorporated, a global biotechnology company, where she was responsible for research and development, business and corporate development, commercial operations, legal, and finance. A certified Public Accountant (CPA), she began her career at Arthur Andersen & Co. Ms. Price currently serves on the Boards of Directors of Accenture plc and Western Digital Corp. She previously served on the Board of Directors of Dollar General Corporation. Prior to joining Schering-Plough, Mr. Bertolini spent 20 years at PricewaterhouseCoopers LLP, leading its global pharmaceutical industry practice.He is a Director of Charles River Laboratories International, Inc. and Idorsia Ltd.Mr. See the complete profile on LinkedIn and discover Giovanni’s connections and jobs at similar companies.
Mr. Paliwal served as Chairman of the Harman Board of Directors from July 2008 to March 2017 when Harman was acquired by Samsung Electronics Co., Ltd. Today it operates as a wholly-owned subsidiary of Samsung.Prior to joining Harman, Mr. Paliwal served as a member of the Group Executive Committee of ABB Ltd., a provider of industrial automation, power transmission systems and services, from January 2001 until June 2007.Mr. Dr. Haller, age 64, has served since 2007 as Ophthalmologist-in-Chief of Wills Eye Hospital in Philadelphia, PA, where she holds the William Tasman, M.D. Giovanni has made over 35 trades of the Bristol Myers Squibb Co stock since 2012, according to the Form 4 filled with the SEC. Vousden, age 61, has been a Senior Group Leader at The Francis Crick Institute in London since February 2017 and Chief Scientist of Cancer Research UK (CRUK) since July 2016. Prior to that, he served as the EVP of global services and CFO for Eli Lilly and Company from 2006 to 2017. From January to July 2016, he was a Partner of Third Rock Ventures, LLC.
Previously, Mr. Bonney served as Chief Executive Officer and a member of the Board of Directors of Cubist Pharmaceuticals Inc. (which was acquired by Merck & Co., Inc. in January 2015) from June 2003 until December 2014. degree from Harvard Medical School.
Instead, the directors tied some elements of his long-term incentive pay to the success of the Celgene integration.That translated to a slight dip in pay for Caforio, as BMS began including “key integration metrics” into its calculations of long-term, share-based incentive awards for senior executives. View Giovanni Caforio’s profile on LinkedIn, the world's largest professional community. Ms. Price earned her M.B.A. degree from the University of Chicago and her B.S. One of the world's most renowned retina surgeons, Dr. Haller has innovated translational advances against blindness on many fronts, including sustained drug delivery devices, ocular pharmacotherapy, retinal "chip" implants, gene therapy, telemedicine, and combating health care disparities. Most recently he sold 39,840 units of BMY stock worth $2,497,968 on 31 August 2020.. She is a fellow of the Royal Society and a Foreign Associate of the National Academy of Sciences. degree in accountancy from DePaul University.Former Executive Vice President, CVS Health and President, Pharmacy Benefits Business, CVS Caremark.Mr. From 2002 to 2016 she served as the Director of the CRUK Beatson Institute in Glasgow, prior to which she held leadership roles at the National Cancer Institute in Maryland from 1995 to 2002.Dr.
Arduini also serves on the Board of Directors of ADVAMED (the Advanced Medical Technology Association), the Board of Directors of MDIC (the Medical Device Innovation Consortium), and the Board of Directors of the National Italian American Foundation. Previously, Ms. Yale has served on the boards of various healthcare providers and payers: Kindred Healthcare, Inc. (post-acute care), National Surgical Hospitals, Inc. (specialty hospitals), Value Options (managed behavioral healthcare), Pediatric Services of America (home care) and NeighborCare, Inc (institutional pharmacy).
He is currently a member of The Walt Disney Company’s Board of Directors and previously served on the Board of Directors of Target Corporation. She brings to the Board a deep knowledge of the US healthcare system.She is currently Chair of the Board of Blue Cross Blue Shield of Massachusetts and serves on the Board of DaVita, Inc. Elected to the National Academy of Medicine, she has held many leadership roles in medicine, is a past member of the Board of Trustees of Princeton University, and a consultant at Children’s Hospital of Philadelphia.